1
|
Leverstein-van Hall MA, Waar K, Muilwijk J, Cohen Stuart J, Sabbe LJM, Frenay HME, Maraha B, van Keulen PHJ, Kluytmans JAJW, de Jongh BM, Vlaminckx BJM, de Brauwer EIGB, Stals FS, Bakker LJ, Dorigo-Zetsma JW, Sebens FW, Mattsson EE, Kaan JA, Thijsen SFT, Buiting AGM, Wintermans RGF, van Hees BC, Brimicombe RW, Ruijs GJHM, Wolfhagen MJHM, van Zeijl JH, Waar K, Renders NHM, Bernards AT, Wintermans RGF, Heilmann FGC, Halaby T, Overbeek BP, Schellekens JFP, Jansen CL, Vlaspolder F, Alblas J, van der Bij AK, Leenstra T, Leversteijn-van Hall MA, Monen J, Muilwijk J, Tjhie HT, Sturm PDJ, Diederen BMW, van Zwet AA, Deege MPD, Boel CHE, Cohen Stuart J, Hendrickx BGA. Consequences of switching from a fixed 2 : 1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli. J Antimicrob Chemother 2013; 68:2636-40. [DOI: 10.1093/jac/dkt218] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
2
|
|
3
|
Gagliotti C, Balode A, Baquero F, Degener J, Grundmann H, Gür D, Jarlier V, Kahlmeter G, Monen J, Monnet DL, Rossolini GM, Suetens C, Weist K, Heuer O, the EARS-Net Participants (Disease C. Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill 2011; 16. [DOI: 10.2807/ese.16.11.19819-en] [Citation(s) in RCA: 116] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
4
|
|
5
|
Borg M, Tiemersma E, Scicluna E, van de Sande-Bruinsma N, de Kraker M, Monen J, Grundmann H. Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern Mediterranean region. Clin Microbiol Infect 2009; 15:232-7. [DOI: 10.1111/j.1469-0691.2008.02651.x] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
6
|
Borg MA, van de Sande-Bruinsma N, Scicluna E, de Kraker M, Tiemersma E, Monen J, Grundmann H. Antimicrobial resistance in invasive strains of Escherichia coli from southern and eastern Mediterranean laboratories. Clin Microbiol Infect 2008; 14:789-96. [PMID: 18727803 DOI: 10.1111/j.1469-0691.2008.02037.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
From January 2003 to December 2005, 5091 susceptibility test results from invasive isolates of Escherichia coli, collected from blood cultures and cerebrospinal fluid routinely processed within 58 participating laboratories, were investigated. These laboratories in turn serviced 64 hospitals in Algeria, Cyprus, Egypt, Jordan, Lebanon, Malta, Morocco, Tunisia and Turkey. The median proportion of resistance to third-generation cephalosporins for the duration of the project was 18.9% (interquartile range (IQR): 12.5-30.8%), and for fluoroquinolones 21.0% (IQR: 7.7-32.6%). A substantial proportion of strains reported by laboratories in countries east of the Mediterranean exhibited evidence of multiresistance, the highest proportion being from Egypt (31%). There is clearly a need for further investigation of potential causes of the significant resistance identified, as well as for strengthening of national and international surveillance initiatives within this region.;
Collapse
Affiliation(s)
- M A Borg
- Infection Control Unit, Mater Dei Hospital, Msida, Malta
| | | | | | | | | | | | | | | |
Collapse
|
7
|
Tiemersma E, van de Sande N, Kahlmeter G, de Kraker M, Monen J, Grundmann H, EARSS participants. O362 Pseudomonas aeruginosa resistance rates in association with level of hospital care: data from the EARSS. Int J Antimicrob Agents 2007. [DOI: 10.1016/s0924-8579(07)70244-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
8
|
Borg M, Scicluna E, van de Sande-Bruinsma N, de Kraker M, Tiemersma E, Monen J, Grundmann H. O114 Prevalence of methicillin-resistant Staphylococcus aureus in the southern and eastern Mediterranean final results from the ARMed project. Int J Antimicrob Agents 2007. [DOI: 10.1016/s0924-8579(07)70083-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
9
|
van de Sande-Bruinsma N, Kahlmeter G, de Kraker M, Tiemersma E, Monen J, Grundmann H, EARSS participants. O359 Is the ratio of associated Escherichia coli resistance comparable over Europe? Int J Antimicrob Agents 2007. [DOI: 10.1016/s0924-8579(07)70241-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
10
|
Monen J, van de Sande-Bruinsma N, Tiemersma E, de Kraker M, Grundmann H, EARSS participants. O360 Multidrug-resistance among invasive Klebsiella pneumoniae in Europe in 2005, the first full year of EARSS reporting. Int J Antimicrob Agents 2007. [DOI: 10.1016/s0924-8579(07)70242-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
11
|
Borg MA, Scicluna E, De Kraker M, Van de Sande-Bruinsma N, Tiemersma E, Gür D, Ben Redjeb S, Rasslan O, Elnassar Z, Benbachir M, Pieridou Bagatzouni D, Rahal K, Daoud Z, Grundmann H, Monen J. Antibiotic resistance in the southeastern Mediterranean - preliminary results from the ARMed project. ACTA ACUST UNITED AC 2006; 11:11-12. [PMID: 29208166 DOI: 10.2807/esm.11.07.00639-en] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Sporadic reports from centres in the south and east of the Mediterranean have suggested that the prevalence of antibiotic resistance in this region appears to be considerable, yet pan-regional studies using comparable methodology have been lacking in the past. Susceptibility test results from invasive isolates of Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Enterococcus faecium and faecalis routinely recovered from clinical samples of blood and cerebrospinal fluid within participating laboratories situated in Algeria, Cyprus, Egypt, Jordan, Lebanon, Malta, Morocco, Tunisia and Turkey were collected as part of the ARMed project. Preliminary data from the first two years of the project showed the prevalence of penicillin non-susceptibility in S. pneumoniae to range from 0% (Malta) to 36% (Algeria) [median: 29%] whilst methicillin resistance in Staphylococcus aureus varied from 10% in Lebanon to 65% in Jordan [median: 43%]. Significant country specific resistance in E. coli was also seen, with 72% of isolates from Egyptian hospitals reported to be resistant to third generation cephalosporins and 40% non-susceptible to fluoroquinolones in Turkey. Vancomycin non-susceptibility was only reported in 0.9% of E. faecalis isolates from Turkey and in 3.8% of E. faecium isolates from Cyprus. The preliminary results from the ARMed project appear to support previous sporadic reports suggesting high antibiotic resistance in the Mediterranean region. They suggest that this is particularly the case in the eastern Mediterranean region where resistance in S. aureus and E. coli seems to be higher than that reported in the other countries of the Mediterranean.
Collapse
Affiliation(s)
- M A Borg
- Infection Control Unit, St. Luke's Hospital, G'Mangia MSD08, Malta
| | - E Scicluna
- Infection Control Unit, St. Luke's Hospital, G'Mangia MSD08, Malta
| | - M De Kraker
- National Institute of Public Health and the Environment, Department of Infectious Disease Epidemiology, Bilthoven, The Netherlands
| | - N Van de Sande-Bruinsma
- National Institute of Public Health and the Environment, Department of Infectious Disease Epidemiology, Bilthoven, The Netherlands
| | - E Tiemersma
- National Institute of Public Health and the Environment, Department of Infectious Disease Epidemiology, Bilthoven, The Netherlands
| | - D Gür
- Clinical Microbiology Laboratory, Hacettepe University, Ankara, Turkey
| | - S Ben Redjeb
- Microbiology Laboratory, Hospital Charles Nicolle, Tunis, Tunisia
| | - O Rasslan
- Infectious Disease Research and Infection Control Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt
| | - Z Elnassar
- Pathology and Microbiology Department, Jordan University of Science and Technology, Irbid, Jordan
| | - M Benbachir
- Microbiology Laboratory, Faculty of Medicine, Casablanca, Morocco
| | | | - K Rahal
- Institute Pasteur, Alger, Algeria
| | - Z Daoud
- Microbiology Laboratory, St. George University Hospital, Beirut, Lebanon
| | - H Grundmann
- National Institute of Public Health and the Environment, Department of Infectious Disease Epidemiology, Bilthoven, The Netherlands
| | - J Monen
- National Institute of Public Health and the Environment, Department of Infectious Disease Epidemiology, Bilthoven, The Netherlands
| |
Collapse
|
12
|
Borg MA, Scicluna E, de Kraker M, van de Sande-Bruinsma N, Tiemersma E, Gür D, Ben Redjeb S, Rasslan O, Elnassar Z, Benbachir M, Pieridou Bagatzouni D, Rahal K, Daoud Z, Grundmann H, Monen J. Antibiotic resistance in the southeastern Mediterranean--preliminary results from the ARMed project. Euro Surveill 2006; 11:164-7. [PMID: 16966796] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/11/2023] Open
Abstract
Sporadic reports from centres in the south and east of the Mediterranean have suggested that the prevalence of antibiotic resistance in this region appears to be considerable, yet pan-regional studies using comparable methodology have been lacking in the past. Susceptibility test results from invasive isolates of Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Enterococcus faecium and faecalis routinely recovered from clinical samples of blood and cerebrospinal fluid within participating laboratories situated in Algeria, Cyprus, Egypt, Jordan, Lebanon, Malta, Morocco, Tunisia and Turkey were collected as part of the ARMed project. Preliminary data from the first two years of the project showed the prevalence of penicillin non-susceptibility in S. pneumoniae to range from 0% (Malta) to 36% (Algeria) [median: 29%] whilst methicillin resistance in Staphylococcus aureus varied from 10% in Lebanon to 65% in Jordan [median: 43%]. Significant country specific resistance in E. coli was also seen, with 72% of isolates from Egyptian hospitals reported to be resistant to third generation cephalosporins and 40% non-susceptible to fluoroquinolones in Turkey. Vancomycin non-susceptibility was only reported in 0.9% of E. faecalis isolates from Turkey and in 3.8% of E. faecium isolates from Cyprus. The preliminary results from the ARMed project appear to support previous sporadic reports suggesting high antibiotic resistance in the Mediterranean region. They suggest that this is particularly the case in the eastern Mediterranean region where resistance in S. aureus and E. coli seems to be higher than that reported in the other countries of the Mediterranean.
Collapse
Affiliation(s)
- M A Borg
- Infection Control Unit, St. Luke's Hospital, G'Mangia MSD08, Malta
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Abstract
(And with EARSS participants) The latest EARSS results (1990-2000) suggest that the rates of methicillin resistant S. aureus and Penicillin Non Susceptible S. pneumoniae are higher in southern European countries than in the North. Young children, followed by elderly people are the most at risk for an infection by PNSP. The risk to be infected by methicillin resistant S. aureus increases with age, patients hospitalised in intensive care units being more exposed to that risk.
Collapse
Affiliation(s)
- S L Bronzwaer
- National Institute of Public health and the Environment, Bilthoven, The Netherlands
| | | | | | | | | |
Collapse
|
14
|
Abstract
Experiments were designed to establish whether we can use the optic flow to detect changes in our own velocity. Subjects were presented with simulations of forward motion across a flat surface. They were asked to respond as quickly as possible to a step increase in simulated ego-velocity. The smallest change for which subjects could respond within 500 ms was determined. At realistic simulated speeds of locomotion, the simulated ego-velocity had to increase by about 50%. The threshold for detecting changes in simulated ego-velocity was hardly better than the threshold for detecting other changes in the acceleration of the dots on the screen. It made little difference whether the surface across which the subject appeared to move was built up of dots, lines, or triangles; neither did it matter whether subjects saw the same image with both eyes, or whether the simulation was presented in stereoscopic depth. The results show that we are very poor at detecting changes in our own velocity on the basis of visual input alone.
Collapse
Affiliation(s)
- J Monen
- Comparative Physiology and Utrecht Biophysics Research Institute, Utrecht University, The Netherlands
| | | |
Collapse
|